London, United Kingdom, March 14, 2019 --(PR.com
)-- SMi Group are delighted to have Dr Joël Richard chairing the two-day conference. Dr Richard is presently leading the Technical and Pharmaceutical Development activities for the Medincell Company, Lead Candidate Selection to all Clinical Development Phases.
Read the letter from the chair:
"As Chair of the 2nd Annual Injectable Drug Delivery Conference, this is my pleasure to invite you to attend this event taking place on May 15-16, 2019 in London.
"This second session of the SMi Annual Injectable Drug Delivery Conference will bring together tremendous expertise in multiple fields of Injectable Drug Delivery. The two-day compact agenda will offer a series of presentations, through which you will gain key insights into current trend and innovations in injectable drug delivery, assessing and discussing the innovation in formulations and devices for injectable delivery.
"Key challenges in injectable drug delivery are related to the administration of high concentration, high viscosity and high-volume formulations of more and more complex molecules, like biologics, and to the design and development of long-acting injectables. Rapidly changing regulatory environment should also be taken into account to drive innovative development and ensure compliance with quality systems. Then, devices appear as strong enablers to market success, becoming more and more sophisticated and bringing additional functionalities. Patient centricity is driving the future of injectable drug delivery market, and digital enhancement and device connectivity will help improve patient treatment compliance and healthcare professional’s security.
"Delegates will gain many invaluable insights from this event, on major topics such as:
· Formulation development and device optimization, focusing on challenges of injectable protein delivery and long acting injectables,
· Regulatory updates and patient safety, highlighting the changes in combination product regulations and the perspective on the new EU MDR,
· Injectable device connectivity, providing an update on the progress in electronic and connected injectables, and more generally speaking in the development of digital into healthcare products
· Manufacturing, filling and Quality control, addressing the challenges of manufacturing of high viscosity, high volume and long acting injectables, especially for biologics.
"Prior to the main event, one pre-conference half-day workshop will be held on Tuesday, May 14, 2019. It will provide you with the opportunity to broaden your knowledge and discuss the 'Use-related risk analysis throughout a design and development project,' understanding how Human Factors relate to the overall design and development process.
"As the Chair of this event, I look forward to personally welcoming you and having fruitful scientific and technical discussion at this must-attend event in London this May."
To read Dr Joël Richard’s full biography and other content including the agenda, speaker line up, and workshop, visit the event website at http://www.injectable-drug-delivery.com/prcom4
The highly anticipated event will gather an international audience to include regulatory, device design, packaging and formulation professionals.
For those interested in attending, there is currently a £200 Early Bird discount on bookings expiring at midnight on Friday 29th March 2019. Places can be reserved at http://www.injectable-drug-delivery.com/prcom4
Injectable Drug Delivery
Date: 15th – 16th May 2019
Workshop: 14th May 21019
Location: Copthorne Tara Hotel Kensington, London
Sponsors: Almac, Crux and Eveon
For all media inquiries, contact Jinna Sidhu on Tel: +44 (0)20 7827 6048 / Email: firstname.lastname@example.org
About SMi Group:
Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world's most forward-thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk